DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

 

MRI Homepage

Elekta to add functional imaging capabilities and take more time to validate MR-linac system Expects CE approval in first half of 2018

Aspect Imaging scores CE mark for its Embrace Neonatal MR system Already in use in Israel

Updated guidelines recommend use of S-ICDs for patients with ventricular arrhythmia Call to action for physicians

Study cautions against trust in MR results for axial spondyloarthritis MR scans are prone to produce positive results for axSpA in healthy individuals

Mallinckrodt Institute of Radiology installs first Siemens MAGNETOM Vida in the US First Siemens MR scanner to carry BioMatrix technology

MR study shows how different football positions impact brain damage First time DTI and fMRI used in conjunction

Action star Chuck Norris, wife Gena, sue eleven organizations over gadolinium Allege MR contrast agent 'nearly killed her'

Swedish researchers map brains of patients with prosthetic limbs using 7T MR Progress in pursuit of fake limbs that feel real

Using functional MR to predict suicidal tendencies Revealing alterations in brain patterns in response to concepts such as death, cruelty, and trouble

Getting the most from your MR coils As these systems get more complicated, so does repairing them

Nuclear localization of
gadolinium deposits

Gadolinium retention may be more widespread than previously thought

by Lauren Dubinsky , Senior Reporter
A new study published in Radiology revealed that gadolinium retention might be more widespread than previously thought.

Gadolinium contrast agents are used in 40 to 50 percent of MR scans performed today, according to Dr. Robert J. McDonald of the Mayo Clinic. Approximately 400 million doses of gadolinium have been administered since it was introduced in 1988.

Story Continues Below Advertisement

The (#1 Resource) for Medical Imaging and Peripherals. Call 1-949-273-8000

As a Master Distributor for major brands Barco, Philips, and Sony, we offer custom imaging solutions. With our renowned OEM Solutions and Service/Repair Center, Ampronix is a one-stop shop for HD Medical LCD Displays--Printers--Recorders--4K Cameras



In late 2014, evidence emerged that gadolinium was depositing within brain tissues. But many of those patients had underlying medical conditions like brain tumors or infections that can compromise the blood brain barrier.

McDonald and his team questioned whether the gadolinium deposition was related to the integrity of the blood-brain barrier, so they studied patients with normal brain pathology.

The team evaluated postmortem neuronal tissue samples from five patients who underwent four or more gadolinium-enhanced MR exams between 2005 and 2015, and 10 patients who underwent MR exams without the contrast agent.

The median age at the time of death was 68 years in the gadolinium-exposed group and 79 years in the control group. At the time of autopsy, all study patients had normal brain pathology.

The tissue samples were studied with transmission electron microscopy, mass spectroscopy and X-ray spectroscopy. They found dose-dependent gadolinium deposits in four neuroanatomical regions of the brain, in patients who underwent control-enhanced MR exams.

“Our results suggest current thinking with regard to the permeability of the blood-brain barrier is greatly oversimplified, as gadolinium appears to accumulate even among patients with normal brain tissue and no history of intracranial pathology.” McDonald said in a statement.

The regions of the brain that retained more gadolinium were the globus pallidus and dentate nucleus. Those regions are prone to mineralization and hemorrhage, which means the blood brain barrier may be less robust in those areas.

Free gadolinium is also similar in size and charge to calcium, which is often taken up in areas of the brain during the aging process. The body may be mistaking the contrast agent for calcium.

But McDonald notes that more research is needed to understand exactly how and why this deposition is occurring.

The good news is that the researchers didn't detect any histologic changes that suggest toxicity in patients who were exposed to gadolinium.

To support that, the FDA announced, in July 2015, that it has found no convincing evidence to date that gadolinium deposition is harmful. But the agency will continue to further investigate this matter.

Back to HCB News
  Pages: 1

MRI Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2017 DOTmed.com, Inc.
ALL RIGHTS RESERVED